The US pharmaceutical giant Merck Sharp & Dohme (MSD) s China branch announced on Wednesday that, to meet the needs of Chinese patients and help China s fight against COVID-19, MSD launched licensing negotiations with Sinopharm to manufacture and supply molnupiravir in China.
Stock futures slip lower on hawkish Fed signals; Powell speech in focus as rate bets test tightening path; Pfizer may sell Covid treatment in China through local partner; Oak Street Health soars on $10 billion CVS takeover report and Microsoft said to eye $10 billion OpenAI investment.
Pfizer CEO rules out generic COVID drug Paxlovid for China bworldonline.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bworldonline.com Daily Mail and Mail on Sunday newspapers.